News 18 mar 2024 Neuria enters Vanguard Accelerator to gameify healthier lifestyles Neuria Digital Therapeutics has become the inaugural start-up of 2024 to be embraced by the Vanguard Accelerator program.
News 13 mar 2024 PSI developing new cancer therapy Researchers from the Paul Scherrer Institute (PSI) have developed a radiopharmaceutical to combat metastatic neuroendocrine tumors. After having ...
News 14 fev 2024 University of Fribourg discovers drug to combat age-related neuroinflammation Scientists at the University of Fribourg have uncovered a groundbreaking mechanism that could significantly mitigate age-related neuroinflammatio...
Actualités 18 mar 2024 Neuria intègre l’accélérateur Vanguard pour promouvoir des modes de vie plus sains Neuria Digital Therapeutics est la première start-up de 2024 à bénéficier du programme Vanguard Accelerator.
Actualités 12 jan 2022 ObsEva obtient des résultats positifs dans le traitement de l’endométriose Spécialisée dans la santé des femmes, la société biopharmaceutique genevoise ObsEva a annoncé des résultats préliminaires positifs de l'essai de ...
Aktuell 10 out 2023 MSD bekennt sich zum Standort Luzern MSD Schweiz will von Luzern aus weiter wachsen. Seit seiner Gründung vor 60 Jahren hat das Pharmaunternehmen kantonsweit eine halbe Milliarde Fr...
News 10 mai 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
News 12 jan 2022 ObsEva achieves positive results in the treatment of endometriosis Geneva-based women’s health biopharmaceutical company ObsEva has announced positive topline results from the Phase 3 EDELWEISS 3 trial of linzago...
Actualités 14 fev 2024 L’Université de Fribourg découvre un traitement pour combattre la neuroinflammation liée à l’âge Des scientifiques de l’Université de Fribourg ont découvert un mécanisme révolutionnaire qui pourrait atténuer de manière significative la neuroi...
Event S-GE Schlüssel zum Erfolg: Strategische Faktoren für Geschäftsaktivitäten in Japan 23 abr 2024 10:15–12:10 Zürich Suíça
News 29 jan 2024 Biomanufacturing innovator Stämm opens its European R&D facility in Monthey Stämm, an innovative leader in bioprocessing technology, has announced the opening of its new R&D facility at the BioArk in Monthey, in the canto...
Événements S-GE Facteurs de succès clés pour faire des affaires au Japon 23 abr 2024 10:15–12:10 Zürich Suíça
News 02 jun 2023 Sandoz decides on Basel for headquarters Sandoz AG will continue to have its headquarters in Basel as an independent company. The separation from Novartis is expected to take place in th...
News 30 abr 2024 Johnson & Johnson opens Innovation Hub in Allschwil Johnson & Johnson has opened its first J&J Innovation Hub on the European mainland at the Switzerland Innovation Park Basel Area. This represents...
Aktuell 28 jun 2023 Clear Solutions Labs will von Standort Basel profitieren Die Gründer der Clear Solutions Laboratories stellen in Basel ein Team von Fachleuten in Biotechnologie, Pharmazie und analytischer Biochemie zu...